Financial statements Pharmovit Produkcja

Balance sheet of Pharmovit Produkcja

Company age:
Age:
5 y. 9 m. 27 d.
Share capital:
Share capital:
5 000 PLN

Balance sheet data of PHARMOVIT PRODUKCJA

Year
2020
2021
2022
2023
2024
Total assets 197 649,52 286 340,48 387 188,45 148 284,66 87 535,58
A. Fixed assets - - - - -
B. Current assets 197 649,52 286 340,48 387 188,45 148 284,66 87 535,58
C. Share capital contributions (basic funds) - - - - -
D. Own shares (stocks) - - - - -
Total liabilities 197 649,52 286 340,48 387 188,45 148 284,66 87 535,58
A. Equity 156 648,02 270 233,83 332 503,29 44 077,24 81 343,38
B. Liabilities and provisions for liabilities - 16 106,65 16 106,65 104 207,42 6 192,20
I. Long-term liabilities - - - - -
II. Short-term liabilities - - - - -
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.

  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.